Show
Sort by
-
Report on the Belgian consensus meeting on Colorectal cancer screening
-
CPT-11 and mitomycin-C in heavily pre-treated patients with metastatic colorectal cancer: a belgian multicentre phase II study
-
Gemcitabine and oxaliplatine (GEMOX) in gemcitabine-refractory advanced pancreatic cancer: a phase II study
-
Raltitrexed plus Gemcitabine (TOMGEM) in advanced pancreatic cancer - Results of a Belgian Multicentre Phase II Study
-
Adjuvant gemcitabine (GEM) and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: a multicenter belgian phase II study